Table 2

Characteristics of initially suspected amyotrophic lateral sclerosis cases finally diagnosed with other diseases

DiagnosisnCSF CHIT1 (pg/mL)Serum CHIT1 (pg/mL)CSF NfL (pg/mL)CSF pNfH (pg/mL)
Polyneuropathy132440* (890–14 280)32 900 (18 600–78 400)922 (216–3535)309† (63–1580)
Myopathy72440* (795–58 260)32 350* (25 350–54 950)1202 (406–9165)414† (62–2653)
Myositis53165 (795–9960)30 350 (13 850–123 400)923 (405–3266)374 (242–2096)
Hereditary spastic paraplegia 41725† (650–3990)17 800† (17 450–73 650)630 (168–937)177† (100–244)
Cramp-fasciculation syndrome41240 (281–14 130)26 350† (2810–40 400)595 (469–7622)252 (90–4160)
Chronic inflammatory demyelinating polyneuropathy38640 (1040–39 420)n.a.5104† (3548–6660)1599† (1264–1934)
Somatization disorder42495 (4205–6020)34 125 (14 750–43 900)921 (338–1502)266 (93–225)
Anterior spinal artery syndrome1782027 300891274
Encephalitis12970n.a.34981293
Myelitis1100032 100921252
Peroneal neuropathy115 27046 3501534384
Cervical myelopathy with radiculopathy130 820n.a.43801923
Spinocerebellar ataxia1116560 3001161799
  • *Two values missing

  • †One value missing

  • Given are median values and ranges.

  • CHIT1, chitotriosidase; NfL, neurofilament light chain; pNfH, phosphorylated neurofilament heavy chain.